# EDGAR Filing Document

**Accession Number:** 0001460702
**File Stem:** 0001493152-23-000150
**Filing Date:** 2023-1
**Character Count:** 2334
**Document Hash:** ec49735ac21a50727729825539e634ca
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-000150.hdr.sgml**: 20230203

**ACCESSION NUMBER**: 0001493152-23-000150

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230103

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Qualigen Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001460702
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 263474527
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 2042 CORTE DEL NOGAL
- **STREET 2:** CARLSBAD
- **CITY:** CALIFORNIA
- **STATE:** CA
- **ZIP:** 92011
- **BUSINESS PHONE:** (760) 918-9165

**MAIL ADDRESS:**
- **STREET 1:** 2042 CORTE DEL NOGAL
- **STREET 2:** CARLSBAD
- **CITY:** CALIFORNIA
- **STATE:** CA
- **ZIP:** 92011

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** RITTER PHARMACEUTICALS INC
- **DATE OF NAME CHANGE:** 20090402

![A close up of a logo Description automatically generated](formcorresp_001.jpg)

January 3, 2023

***<u>VIA EDGAR</u>***

United States Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

Attention: Joshua Gorsky

---

| | |
|:---|:---|
| ***Re:*** | ***Qualigen Therapeutics, Inc. – Request for Acceleration*** |
|  | ***Registration Statement on Form S-3*** |
|  | ***File No. 333- 269088*** |

---

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Qualigen Therapeutics, Inc. (the "Registrant") hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333- 269088) (the "Registration Statement"), so that it may become effective at **4:30 p.m. Eastern Standard Time on Thursday, January 5, 2023**, or as soon thereafter as practicable.

The Registrant hereby authorizes Wendy Grasso, Esq. of Reed Smith LLP, attorney for the Registrant, to orally modify or withdraw this request for acceleration.

The Registrant requests that it be notified of such effectiveness by a telephone call to Wendy Grasso, Esq. at (212) 549-0216.

---

| | |
|:---|:---|
| **QUALIGEN THERAPEUTICS, INC.** | **QUALIGEN THERAPEUTICS, INC.** |
| *By:* | */s/ Michael Poirier* |
|  | *Michael Poirier* |
|  | Chairman & Chief Executive Officer |

---